Active Ingredient(s): Clevidipine Butyrate
FDA Approved: * August 1, 2008
Pharm Company: * MEDICINES CO
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Cleviprex Overview

Clevidipine (INN,[2] trade name Cleviprex) is a dihydropyridine calcium channel blocker indicated for the reduction of blood pressure when oral therapy is not feasible or not desirable. It was approved by the United States Food and Drug Administration on August 1, 2008. Contents 1 Basic chemical and pharmacological properties 1.1 Stereochemistry 2 Dosage and administration 3 Safety information 4 Drug interactions 5 Storage 6 Phase III clinical trial results 7 References ...

Read more Cleviprex Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Cleviprex Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Clevidipine Butyrate
  • Emulsion: 0.5mg/ml, 125mg/250ml (0.5mg/ml), 25mg/50ml (0.5mg/ml), 25mg/50ml(0.5mg/ml), 50mg/100ml (0.5mg/ml), 50mg/100ml(0.5mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Cleviprex: (5 results)

Sorted by National Drug Code
  • 10122-610 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
  • 10122-611 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
  • 10122-612 Cleviprex .5 mg/ml Intravenous Emulsion by Chiesi USA, Inc.
  • 18124-011 Cleviprex .5 mg/ml Intravenous Emulsion by Fresenius Kabi Austria Gmbh
  • 65293-005 Cleviprex .5 mg/ml Intravenous Emulsion by The Medicines Company

Other drugs which contain Clevidipine Butyrate or a similar ingredient: (1 result)

Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 31 July 2021.

We are committed to your privacy.

Copyright © 2005-2021 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA